The American Society of Transplantation Online Transplant Infectious Diseases Library
Full Library 1,556 resources
-
Abstract Objectives Antibiotic prophylaxis for patients with cancer remains a controversial issue and is not broadly recommended for hematological malignancies. The venetoclax (VEN) and azacitidine (AZA) combination allows for high rates of complete remission in acute myeloid leukemia (AML) but enhances the incidence of febrile neutropenia (FN) compared to AZA alone, making primary antibiotic prophylaxis a relevant question. ...
-
Learn about clinical diagnosing and treating measles cases.
-
Abstract Background To assess the impact of attaining aggressive β-lactam (BL) pharmacokinetic-pharmacodynamic (PK/PD) targets on clinical efficacy in critically ill orthotopic liver transplant (OLT) recipients with documented early gram-negative infections. Methods The study prospectively enrolled OLT recipients admitted to the posttransplant intensive care unit between June 2021 and May...
-
Abstract Background Multiplex polymerase chain reaction (PCR)-based targeted next-generation sequencing (tNGS) is a promising tool for distinguishing lower respiratory tract infections in clinical practice, and its detectable pathogen spectrum can cover more than 95% of clinical cases, but there is limited information on systematic evaluation of the clinical use of multiplex PCR-based tNGS (mp-tNGS) in invasive pulmonary aspergillosis (IPA) cases....
-
Background: Candida species are the most common cause of invasive fungal disease, and children with hematologic malignancy are at increased risk. Non- albicans Candida (NAC) now account for more than half of all invasive candidiasis (IC) and carry a worse prognosis. We aimed to compare the epidemiology, risk factors, organ dissemination, biomarkers and outcomes in IC based on the species implicated and...
-
This study investigates the prevalence of Trypanosoma cruzi infection among solid organ transplant recipients in the United States from 2019 to 2023 before transplantation. Utilizing data from a large multicenter network, we identified a rising seroprevalence of 4.8% from 1523 solid organ transplant recipients at the time of the evaluation for transplantation, particularly among lung and heart transplant recipients. The findings highlight the need for improved screening protocols to address...
-
In vivo T-cell depletion (TCD) using alemtuzumab decreases the risk of Graft vs Host Disease (GvHD) in recipients of allogeneic hematopoietic stem cell transplant (allo-HSCT). However, this approach increases the risk of infections post-allo-HSCT, including Cytomegalovirus (CMV). Letermovir is approved for the use in CMV prophylaxis post-allo-HSCT. Few studies have investigated the efficacy of letermovir in patients receiving alemtuzumab. This is a single-center retrospective study...
-
The prolonged treatment recommended for nocardiosis does not rely on strong evidence. Consequently, some clinicians opt shorter therapy in certain circumstances. We assessed the effectiveness of shorter therapy.
-
Abstract Follow-up of previously healthy patients surviving cryptococcal meningitis found that cryptococcal antigen could be detected for >1 year in serum from 38 of 44 (86%) patients and in cerebrospinal fluid (CSF) from 20 of 31 patients (67%), far beyond the time of culture conversion. The speed of titer decline, measured as the number of days for a 2-fold drop in titer to occur, was slower in serum than in CSF. The speed of decline of antigen titers was much slower in...
-
Traditional approaches to practice guidelines frequently result in dissociation between strength of recommendation and quality of evidence.To create a clinical guideline for the diagnosis and management of urinary tract infections that addresses the gap between the evidence and recommendation strength.This consensus statement and systematic review applied an approach previously established by the WikiGuidelines Group to construct collaborative clinical guidelines. In May 2023, new and...
-
Evaluations of oral vancomycin prophylaxis (OVP) against Clostridioides difficile have been reported in stem cell transplant populations with short follow-up periods. The longest known duration of standardized follow-up post-OVP is 90 days within an allogeneic stem cell transplant population. In 2017, we implemented OVP 125 mg twice daily in autologous stem cell transplant (ASCT) recipients beginning the day of admission and continued until the day of discharge.Patients who received an ASCT...
-
BACKGROUND Kidney transplantation from donors with human immunodeficiency virus (HIV) to recipients with HIV is an emerging practice. It has been performed since 2016 under the U.S. congressional HIV Organ Policy Equity Act and is currently approved for research only. The Department of Health and Human Services is considering expanding the procedure to clinical practice, but data are limited to small case series that did not include donors without HIV as controls. METHODS In an observational...
-
Human herpesvirus 6B (HHV-6B) frequently reactivates following allogeneic stem cell transplant (alloHCT). Consensus guidelines note that haploidentical alloHCT may represent a high-risk population for which there is little evidence; this warrants further investigation.In this single-center retrospective study, we evaluated 188 consecutive adult patients receiving haploidentical alloHCT between 11/2014 and 11/2020 and compared outcomes between patients with HHV-6B reactivation receiving...
-
<h3>Background</h3><p>Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality worldwide. Limited evidence is available on the most effective diagnostic approaches, management strategies, and long-term outcomes for CAP in patients who have undergone solid organ transplantation.</p><h3>Research Question</h3><p>What is the acute and long-term morbidity and mortality after CAP in organ transplant recipients?</p><h3>Study Design and Methods</h3><p>We retrospectively...
-
Abstract Background Among 547 patients receiving maribavir or valganciclovir for first-episode cytomegalovirus infection after hematopoietic cell transplant, the treatment response rate was 69.6% and 77.4% respectively. Development of maribavir and ganciclovir resistance was compared after receiving either drug. Methods Viral mutations conferring drug resistance were analyzed in plasma DNA...
-
Commentary on https://transplantid.net/J9D9FTF2
Filter by our tag
GUIDELINES
- AASLD Guidelines (5)
- AST Guidelines 2019 (44)
- ASTCT Guidelines 2019-2023 (9)
- DGHO Guidelines (3)
- ECIL Guidelines (18)
- ESCMID Guidelines (25)
- IDSA Guidelines (53)
- ISHLT Guidelines (12)
- NIH Guidelines (1)
- WHO Guidelines (1)
- WikiGuidelines (3)
TEXTBOOKS
CORE CURRICULUM
- BASICS OF TRANSPLANT (35)
- ORGANISMS (44)
- SYNDROMES (13)
ORGANISMS
-
BACTERIA
(159)
- C. difficile (25)
- Legionella (1)
- MDR GNR (38)
- MRSA (7)
- Mycoplasma and Ureaplasma (11)
- Nocardia (11)
- Non-tuberculous Mycobacteria (27)
- Syphilis (6)
- Tuberculosis (33)
- VRE (8)
-
FUNGI
(227)
- Aspergillus (59)
- Candida (48)
- Cryptococcus (29)
- Endemic mycoses (43)
- Mucormycosis (33)
- Pneumocystis (41)
- Rarer Fungi (22)
-
PARASITES AND PROTOZOA
(44)
- Chagas (10)
- Protozoa (12)
- Strongyloides (14)
- Toxoplasmosis (12)
-
VIRUSES
(416)
- Adenovirus (17)
- Arboviruses (7)
-
CMV
(121)
- Cell-Mediated Immunity Assays (11)
- Clinical (56)
- Cytotoxic T-Lymphocytes (1)
- Epidemiology and Risk Factors (15)
- Letermovir (25)
- Maribavir (16)
- Preemptive Therapy (7)
-
COVID-19
(48)
- Diagnosis (4)
- Fungal superinfection (2)
- GUIDELINES (11)
- Infection Prevention (4)
- Positive Donors (6)
- Positive Recipients (5)
- Treatments (18)
- Vaccination (9)
- Hepatitis A (2)
- Hepatitis B (29)
- Hepatitis C (31)
- Hepatitis D (5)
- Hepatitis E (5)
- HHV-6 (23)
- HHV-8 (4)
- HIV (31)
- HPV (5)
- HSV (4)
- Influenza (17)
- Measles (21)
- Mpox (6)
- Norovirus (8)
- Parvovirus B19 (3)
- Polyomaviruses (32)
- Respiratory Viruses (31)
- RSV (18)
- VZV (17)
- WNV (2)
DIAGNOSTICS
- Advanced Diagnostics (23)
- Fungal diagnostics (40)
- Nuclear Medicine (7)
- Parasites (3)
- Procalcitonin (1)
- Viral diagnostics (1)
DRUGS AND THERAPIES
- Antibiotics (12)
- Antifungals (68)
- Antivirals (10)
- Cytotoxic T-lymphocyte therapy (7)
- Fecal Microbiota Transplantation (12)
- Phage therapy (4)
- Stewardship (57)
PREVENTION
- Infection Control (8)
- Safe Living (22)
- Travel (10)
- Vaccination (37)
SYNDROMES AND CONDITIONS
- Cirrhotics (11)
- CNS (3)
- Cytopenias (2)
- Diarrhea (13)
- Endovascular infections (12)
- Pneumonia (11)
- Surgical Infections (8)
- UTI (31)
SOLID ORGANS AND MCSS
- Donor (43)
- Heart (15)
- Immunosuppression (14)
- Intestinal (2)
- Kidney (32)
- Liver (53)
- Lung (69)
- LVAD (31)
- Pancreas (5)
- PEDIATRIC (41)
- Recipient (5)
- Total Artificial Heart (1)
- Vascular Composite Allograft (2)
- Xenotransplantation (3)
HEME-ONC AND CELLULAR THERAPIES
- Biologics (44)
- BMT Basics (5)
- BMT Guidelines (14)
- BMT Noninfectious (12)
- BMT-specific ID (71)
- CAR-T (21)
- CAR-T Noninfectious (3)
- GVHD (4)
- Heme malignancies (4)
- Heme-onc prophylaxis (25)
- Neutropenia (43)
- PEDIATRIC (33)
- PTLD (25)
- TK inhibitors (11)
TRANSPLANT ID TRAINING
- AST (4)
- Career Development (1)
- Fungal (5)
- Training program (6)
PATIENT EDUCATION
- COVID-19 (13)
- Food (10)
- Hygiene (4)
- Mpox (5)
- Pets (4)
- Safer living (16)
- Selected Infections (10)
- TB (10)
- Travel (3)
- Water safety (5)
JOURNAL CLUB
- 2024 (2)